Introduction. The aims of this qualitative study were to explore (a) the factors influencing mothers’ decisions to vaccinate 11- to 12-year-old daughters against human papillomavirus (HPV) and (b) the mothers’ and daughters’ perspectives about HPV vaccine–related decision making. Methods. Participants were girls (N = 33) who had received an HPV vaccine and their mothers (N = 32), recruited from suburban and urban pediatric practices. Semistructured interviews were conducted with girls and mothers separately, and data were analyzed using framework analysis. Results. The primary factors influencing mothers’ decisions to vaccinate daughters against HPV were (a) mother’s beliefs and experiences; (b) interactions with clinicians, friends, and family members; and (c) exposure to media reports/marketing. Most daughters believed the decision to be vaccinated was a mutual one, although most mothers believed the decision was theirs. Conclusions. This study provides novel insights into perspectives on decision making about HPV vaccination among mothers and 11- to12-year-old daughters, which can be used in interventions to improve vaccination rates.
BoschFXde SanjoseS. Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;31:3-13.
2.
Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:626-629.
3.
Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:630-632.
4.
GarlandSMHernandez-AvilaMWheelerCM. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928-1943.
5.
HarperDMFrancoELWheelerCM. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367:1247-1255.
6.
FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-1927.
7.
WallerJMarlowLAWardleJ. Mothers’ attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev. 2006;15:1257-1261.
8.
ConstantineNAJermanP. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40:108-115.
9.
KahnJADingLHuangBZimetGDRosenthalSLFrazierAL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123: 1439-1445.
10.
KahnJACooperHPVadaparampilST. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11- to 12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev. 2009;18:2325-2332.
11.
DaleyMFCraneLAMarkowitzLE. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126:425-433.
12.
GottliebSLBrewerNTSternbergMR. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45:430-437.
13.
WongCABerkowitzZDorellCGPriceRALeeJSaraiyaM. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer. 2011;117:5612-5620.
14.
MarlowLAWallerJWardleJ. Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007;25:1945-1952.
15.
RosenthalSLRuppRZimetGD. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43:239-245.
16.
DempseyAFAbrahamLMDaltonVRuffinM. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19:531-538.
17.
AllenJDOthusMKSheltonRC. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010;19:2187-2198.
RitchieJSpencerL. Qualitative data analysis for applied policy research. In: BrymanABurgessRG, eds. Analyzing Qualitative Data. London, England: Routledge; 1994:173-194.
20.
KahnJASlapGBBernsteinDI. Psychological, behavioral, and interpersonal impact of human papillomavirus and pap test results. J Womens Health (Larchmt). 2005;14:650-659.
21.
TissotAMZimetGDRosenthalSLBernsteinDIWetzelCKahnJA. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health. 2007;41: 119-125.
22.
KahnJARosenthalSLTissotAMBernsteinDIWetzelCZimetGD. Factors influencing pediatricians’ intention to recommend human papillomavirus vaccines. Ambul Pediatr. 2007;7:367-373.
23.
KahnJASlapGBBernsteinDI. Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol. 2007;26:192-200.
24.
GerendMAWeibleyEBlandH. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45:528-531.
ReiterPLBrewerNTGottliebSLMcReeALSmithJS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69:475-480.
27.
CatesJRShaferACarpentierFD. How parents hear about human papillomavirus vaccine: implications for uptake. J Adolesc Health. 2010;47:305-308.
28.
HabelMALiddonNStrykerJE. The HPV vaccine: a content analysis of online news stories. J Womens Health (Larchmt). 2009;18:401-407.
29.
CooperLZLarsonHJKatzSL. Protecting public trust in immunization. Pediatrics. 2008;122:149-153.
30.
MathurMBMathurVSReichlingDB. Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. J Pediatr Health Care. 2010;24:14-24.
31.
Cooper RobbinsSCBernardDMcCafferyKBrothertonJGarlandSSkinnerSR. “Is cancer contagious?”: Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Vaccine. 2010;28:3398-3408.
32.
RobertsMEGerrardMReimerRGibbonsFX. Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics. 2010;125:982-989.
33.
SussmanALHelitzerDSandersMUrquietaBSalvadorMNdiayeK. HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Ann Fam Med. 2007;5:298-304.
34.
BrabinLRobertsSAStretchR. A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer. 2009;101:1502-1504.
35.
HughesCCJonesALFeemsterKAFiksAG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011;11:74.
36.
McReeALReiterPLGottliebSLBrewerNT. Mother-daughter communication about HPV vaccine. J Adolesc Health. 2011;48:314-317.
37.
AskelsonNMCampoSSmithSLoweJBDennisLKAndsagerJ. The birds, the bees, and the HPVs: what drives mothers’ intentions to use the HPV vaccination as a chance to talk about sex?J Pediatr Health Care. 2011;25: 162-170.
